IP Verse

Alfasigma patent opposition analysis

Get complete Patent Opposition Report for Alfasigma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Alfasigma

Explore patent oppositions filed by Alfasigma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3536311Storage Stable Composition Comprising Rifaximin AlphaSANDOZSep 22, 2022
EP3434265Pharmaceutical Composition Containing Rifaximin Alpha & DeltaSANDOZMar 21, 2022
EP3416627Oral Dosage Form Comprising Rifaximin In Form BetaSANDOZAug 27, 2020
EP3373914Storage Stable Composition Comprising Rifaximin AlphaSANDOZJan 24, 2020
EP3294270Pharmaceutical Composition Containing Rifaximin Alpha&DeltaSANDOZJun 12, 2019

Latest patents of Alfasigma opposed by its competitors

Explore Alfasigma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3595667Dec 20, 2023Pharmaceutical Compositions Comprising A Jak Inhibitor3
EP3439637Jun 1, 2022Process For Mesalazine Solid Formulations1
EP2618819Nov 1, 2017Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease1
EP2560662Jun 7, 2017Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved2
EP2059232Apr 19, 2017Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin3

Top competitors of Alfasigma